These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 32337549

  • 1. Frequencies and predictors of the Lupus Low Disease Activity State and remission in treatment-naïve patients with systemic lupus erythematosus.
    Gao D, Hao Y, Mu L, Xie W, Fan Y, Ji L, Zhang Z.
    Rheumatology (Oxford); 2020 Nov 01; 59(11):3400-3407. PubMed ID: 32337549
    [Abstract] [Full Text] [Related]

  • 2. Remission and low disease activity in Polish patients with systemic lupus erythematosus - real-life, five-year follow-up outcomes.
    Pawlak-Buś K, Schmidt W, Leszczyński P.
    Eur Rev Med Pharmacol Sci; 2023 Feb 01; 27(3):949-959. PubMed ID: 36808341
    [Abstract] [Full Text] [Related]

  • 3. Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus.
    Tsang-A-Sjoe MW, Bultink IE, Heslinga M, Voskuyl AE.
    Rheumatology (Oxford); 2017 Jan 01; 56(1):121-128. PubMed ID: 27803306
    [Abstract] [Full Text] [Related]

  • 4. Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission.
    Zen M, Iaccarino L, Gatto M, Saccon F, Larosa M, Ghirardello A, Punzi L, Doria A.
    Ann Rheum Dis; 2018 Jan 01; 77(1):104-110. PubMed ID: 28970217
    [Abstract] [Full Text] [Related]

  • 5. Treatment Target in Newly Diagnosed Systemic Lupus Erythematosus: The Association of Lupus Low Disease Activity State and Remission With Lower Accrual of Early Damage.
    Floris A, Piga M, Perra D, Chessa E, Congia M, Mathieu A, Cauli A.
    Arthritis Care Res (Hoboken); 2020 Dec 01; 72(12):1794-1799. PubMed ID: 31600023
    [Abstract] [Full Text] [Related]

  • 6. Flare rates and factors determining flare occurrence in patients with systemic lupus erythematosus who achieved low disease activity or remission: results from a prospective cohort study.
    Hao Y, Ji L, Gao D, Fan Y, Geng Y, Zhang X, Li G, Zhang Z.
    Lupus Sci Med; 2022 Mar 01; 9(1):. PubMed ID: 35241499
    [Abstract] [Full Text] [Related]

  • 7. Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus.
    Morand EF, Abreu G, Furie RA, Golder V, Tummala R.
    Ann Rheum Dis; 2023 May 01; 82(5):639-645. PubMed ID: 36690388
    [Abstract] [Full Text] [Related]

  • 8. Comparison of Remission and Lupus Low Disease Activity State in Damage Prevention in a United States Systemic Lupus Erythematosus Cohort.
    Petri M, Magder LS.
    Arthritis Rheumatol; 2018 Nov 01; 70(11):1790-1795. PubMed ID: 29806142
    [Abstract] [Full Text] [Related]

  • 9. Remission and low disease activity in systemic lupus erythematosus: an achievable goal even with fewer steroids? Real-life data from a monocentric cohort.
    Tani C, Vagelli R, Stagnaro C, Carli L, Mosca M.
    Lupus Sci Med; 2018 Nov 01; 5(1):e000234. PubMed ID: 29531772
    [Abstract] [Full Text] [Related]

  • 10. Predicting lupus low disease activity state and remission in SLE: novel insights.
    Gao D, Hao Y, Fan Y, Ji L, Zhang Z.
    Expert Rev Clin Immunol; 2021 Oct 01; 17(10):1083-1089. PubMed ID: 34392757
    [Abstract] [Full Text] [Related]

  • 11. LLDAS is an attainable treat-to-target goal in childhood-onset SLE.
    Wahadat MJ, van den Berg L, Timmermans D, van Rijswijk K, van Dijk-Hummelman A, Bakx S, Verkaaik M, Versnel MA, Kamphuis S.
    Lupus Sci Med; 2021 Dec 01; 8(1):. PubMed ID: 34969874
    [Abstract] [Full Text] [Related]

  • 12. Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab.
    Morand EF, Trasieva T, Berglind A, Illei GG, Tummala R.
    Ann Rheum Dis; 2018 May 01; 77(5):706-713. PubMed ID: 29420200
    [Abstract] [Full Text] [Related]

  • 13. Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus.
    Piga M, Floris A, Cappellazzo G, Chessa E, Congia M, Mathieu A, Cauli A.
    Arthritis Res Ther; 2017 Nov 10; 19(1):247. PubMed ID: 29126432
    [Abstract] [Full Text] [Related]

  • 14. Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience.
    Tani C, Elefante E, Signorini V, Zucchi D, Lorenzoni V, Carli L, Stagnaro C, Ferro F, Mosca M.
    RMD Open; 2019 Nov 10; 5(2):e000916. PubMed ID: 31275608
    [Abstract] [Full Text] [Related]

  • 15. Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study.
    Ramirez GA, Canti V, Moiola L, Magnoni M, Rovere-Querini P, Coletto LA, Dagna L, Manfredi AA, Bozzolo EP.
    Int J Rheum Dis; 2019 Sep 10; 22(9):1752-1761. PubMed ID: 31379114
    [Abstract] [Full Text] [Related]

  • 16. Low disease activity state in juvenile-onset systemic lupus erythematosus.
    Ozturk K, Caglayan S, Tanatar A, Baglan E, Yener Otar G, Kavrul Kayaalp G, Karadag SG, Demir F, Sonmez HE, Ozdel S, Cakan M, Aktay Ayaz N, Sozeri B, PeRA-Research Group.
    Lupus; 2021 Nov 10; 30(13):2144-2150. PubMed ID: 34723709
    [Abstract] [Full Text] [Related]

  • 17. Caveats and pitfalls in defining low disease activity in systemic lupus erythematosus.
    Samões B, Zen M, Abelha-Aleixo J, Gatto M, Doria A.
    Autoimmun Rev; 2022 Oct 10; 21(10):103165. PubMed ID: 35931316
    [Abstract] [Full Text] [Related]

  • 18. LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort.
    Ugarte-Gil MF, Gamboa-Cardenas RV, Reátegui-Sokolova C, Pimentel-Quiroz VR, Medina M, Elera-Fitzcarrald C, Zevallos F, Pastor-Asurza CA, Lofland J, Zazzetti F, Karyekar CS, Alarcón GS, Perich-Campos RA.
    Lupus Sci Med; 2022 Feb 10; 9(1):. PubMed ID: 35193948
    [Abstract] [Full Text] [Related]

  • 19. Lupus low disease activity state within 12 months is associated with favourable outcomes in severely active systemic lupus erythematosus.
    Kikuchi J, Hanaoka H, Saito S, Oshige T, Hiramoto K, Kaneko Y, Takeuchi T.
    Rheumatology (Oxford); 2022 Aug 30; 61(9):3777-3791. PubMed ID: 35015824
    [Abstract] [Full Text] [Related]

  • 20. How can we define low disease activity in systemic lupus erythematosus?
    Tselios K, Gladman DD, Urowitz MB.
    Semin Arthritis Rheum; 2019 Jun 30; 48(6):1035-1040. PubMed ID: 30415943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.